Innovation & Entrepreneurship News

Berkeley Web3 and Crypto Summit Tackles Financial Inclusion, Climate Issue

How do we incentivize the use of climate-friendly blockchains? Should lawmakers play a key role in creating opportunities for underserved communities via crypto assets and Web3? And what can the crypto asset industry do to ensure wealth-building opportunities are accessible to historically excluded communities?

David Schaffer: Research That Takes Risks Must be Supported

David Schaffer remembers sitting on his father’s lap as a child, curiously delving into science books and crafting mnemonic phrases that instilled in him the building blocks of biology. Recently, Schaffer was appointed the new executive director of QB3, a UC-systemwide group that supports California entrepreneurship. Schaffer also leads the Bakar BioEnginuity Hub, which will hold 50 new biotechnology startup companies supported by the Bakar Labs incubator, and he directs Berkeley’s Bakar Fellows Program, a funding incubator that accelerates the application of discovery research.

QB3 Welcomes David Schaffer as Its New Executive Director

David Schaffer, PhD, a University of California, Berkeley professor of chemical and biomolecular engineering, bioengineering, and molecular and cell biology, has been appointed the next executive director of QB3, the institute announced today.

Berkeley’s Bakar BioEnginuity Hub Opens Its Doors

UC Berkeley’s campus community this week celebrated the grand opening of the Bakar BioEnginuity Hub (BBH), the campus’s bold new home for research and innovation. After two years of seismic upgrades and renovations, BBH celebrated its opening this month. Bakar Labs, the facility’s flagship life sciences incubator, has been operational since mid-November, offering space to tenant companies.

Engineering a Hungry Bacterium to Protect Public Health

Microbiologist Cecilia Martinez-Gomez studies a widespread specie of bacteria that thrives on rare earth elements, also known as rare earth metals or lanthanides. She has engineered one strain of the bacteria to efficiently accumulate a rare earth element known as neodymium from electronics waste and recycle it back to the industry for making batteries, speakers, even jet turbines.

Removing a Potential MRI Risk - Literally

More than 40 million MRI scans are carried out every year in the U.S.  In about one out of three, patients get an infusion containing the metal gadolinium as a contrast agent to improve imaging. Because contrast MRIs sometimes lead to potentially life-threatening complications, the FDA issued a warning against contrast MRIs for patients with kidney disease. Rebecca Abergel studies the chemical biology of metals, with a research focuses on organic molecules that can sequester and eliminate metals in the body, a chemical process known as chelation. She is using her Bakar Fellow support to evaluate the effectiveness of a chelating drug she has developed.